Medicinal Organic Cannabis Australia (MOCA) Pty Ltd: Supplying Medicinal Cannabis to France
Medicinal Organic Cannabis Australia (MOCA) Pty Ltd is a trusted supplier of premium, GMP-certified Australian-grown medicinal cannabis products. With a commitment to delivering safe, effective, and high-quality cannabis-based treatments, MOCA is proud to serve the growing medicinal cannabis market in France. With export licences and approvals from the Australian Office of Drug Control (ODC), we are equipped to meet the needs of the French market with our top-tier products.
At MOCA, we are dedicated to ensuring the highest standards of product quality and compliance. As an Australian-based company, we adhere to international best practices, guaranteeing that our cannabis products are safe, effective, and consistent. All of our cannabis is cultivated in accordance with Good Manufacturing Practice (GMP), ensuring that each product is of the highest quality.
MOCA holds the necessary licences to export medicinal cannabis, allowing us to meet the stringent regulatory requirements set by both Australian authorities and French regulators. Whether you are a pharmaceutical company, a healthcare provider, or a patient seeking medicinal cannabis solutions, MOCA offers a reliable and compliant supply of premium cannabis products tailored to your needs.
MOCA provides a broad range of medicinal cannabis products, available in both raw and finished formats, designed to address various therapeutic needs.
Raw Cannabis Products: We offer high-quality bulk cannabis flowers, grown in strict accordance with GMP standards. These flowers are free from harmful pesticides and chemicals, ensuring a pure, safe product suitable for pharmaceutical and medicinal use.
Finished Products: In addition to raw cannabis, MOCA produces a variety of finished cannabis products, including oils, capsules, and extracts. Each product is carefully formulated to ensure precise dosages, with varying levels of THC and CBD to suit different therapeutic requirements. Our finished products deliver reliable and consistent outcomes for patients.
Each product undergoes comprehensive testing to meet international pharmaceutical standards, ensuring that our customers receive effective treatments with reliable results.
MOCA is fully committed to adhering to both Australian and French regulations regarding the importation and use of medicinal cannabis. We work closely with French authorities to ensure that our products comply with local laws and medical cannabis regulations.
France operates a regulated medical cannabis programme, and we are pleased to support the country's efforts to expand access to cannabis-based therapies. Our products meet the regulatory requirements established by the French Medicines Agency (ANSM), ensuring their suitability for medical use within France.
Australia’s world-class agricultural standards and ideal growing conditions make it one of the top producers of high-quality cannabis. At MOCA, we grow our cannabis using organic farming methods, ensuring that our products are free from harmful chemicals and pesticides.
Australia’s robust regulatory environment ensures that all cannabis products exported from the country are safe, consistent, and effective. This makes MOCA’s Australian-grown cannabis an excellent choice for the French medical cannabis market.
MOCA is eager to become a trusted supplier of medicinal cannabis to pharmaceutical companies, healthcare providers, and other stakeholders in France. Whether you are seeking bulk raw cannabis or finished products, we offer tailored solutions that align with the needs of the French medical market.
Our experienced team is available to assist you with any questions related to product selection, regulatory compliance, and logistical support. Partnering with MOCA means you will have access to a reliable, compliant, and high-quality supply of medicinal cannabis products.